BIOLOGICAL · Unmapped registry intervention
MUC1 Peptide Vaccine
Find medicine records ·
Find other trials using this name
Clinical trial
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
NCT06218303
Study summary
ClinicalTrials.govPrototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Hiltonol®
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Aromatase Inhibitor
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Selective estrogen receptor modulator (SERM)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Interventions
Sponsors & collaborators
Finn, Olivera, PhDlead sponsor
A Glimmer of Hope Foundationcollaborator
Breast Cancer Research Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06218303 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.